Inventor
Ian SARVARY
Inventor
DK
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes26%
PatentTitleYear
12,441,704Compounds active towards nuclear receptors202511,845,760PRMT5 inhibitors202311,780,843Compounds active towards nuclear receptors202311,685,727Compounds active towards nuclear receptors202311,613,532Compounds active towards nuclear receptors202311,447,479Compounds active towards nuclear receptors202211,254,681Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to NUEVOLUTION AS (6)· patent assignee history
2022–2025Based in DK· patent location history
2023Patents assigned to AMGEN INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NUEVOLUTION AS | 6 | 2022–2025 |
| AMGEN INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| DK | 7 | 2022–2025 |